• Home
• PharmTech.com
• About
• Contact
• Newsletters
• Subscribe/RSS

Author Archive

• Categories

  Select Category Africa News  (3) Analytics  (25) Asia News  (12) Biotech  (70) Drug Delivery  (27) Europe News  (23) Formulation  (23) Industry conferences  (47) Information Technology  (25) Ingredients  (46) INTERPHEX 2008  (19) INTERPHEX 2009  (6) Latin & South America News  (3) Manufacturing  (115) North America News  (61) Outsourcing  (26) Packaging & Labeling  (16) Products  (37) Products & Equipment  (6) R&D  (94) Regulation  (186) Trends  (144) Uncategorized  (5) Welcome!  (1)

• Authors

  • A. Nair, Mumbai correspondent (2)
  • Alexis Pellek (54)
  • Angie Drakulich (86)
  • Corrine Lawrence, PharmTech Europe (2)
  • Daniel R. Matlis, president of Axendia (1)
  • Erik Greb (82)
  • Fedra Pavlou, PharmTech Europe (4)
  • Girish Malhotra, PE, president of EPCOT International (1)
  • Helen Disney (1)
  • Jamie Carpenter, multimedia producer, Advanstar (1)
  • Jill Wechsler, Washington editor (4)
  • Jlaw (1)
  • Joe Acker, SOCMA president (1)
  • Julian Upton (1)
  • Maribel Rios (61)
  • Michelle Hoffman (9)
  • Patricia Van Arnum (83)
  • Reflector (2)
  • Stephanie Sutton, PharmTech Europe (10)
  • Various Attendees (1)

• Recent Posts

  • Framing the argument
  • Pharma Companies and Suppliers Meet at DCAT Week
  • Biopharmaceutical Collaboration Is a Sign of the Times
  • Life After Big Pharma
  • PhRMA Details Its Proposal for Internet and Social-Media Standards

• PharmTech Poll

  Recession
  In light of the fact that most of the world is now out of the recession, how is your company faring compared with this time last year?

  Vote Here

• Popular Tags

  biopharmaceuticals biotechnology cancer clinical trials contamination counterfeiting Drug Delivery Eli Lilly FDA FDA inspections Genentech generic GlaxoSmithKline Grassley H1N1 flu healthcare heparin HIV/AIDS ICH innovation Manufacturing marketing Merck mergers and acquisitions nanotechnology Obama Outsourcing patent patient Pfizer pharmaceuticals PhRMA prescription QbD Regulation research and development RFID Roche Sanofi Schering-Plough Senate supply chain swine flu vaccine Wyeth

• From PharmTech.com

  • Rheumatoid arthritis treatment suspended
  • Pharmaceutical Safety Program Launched
  • WHO Releases New Malaria Treatment and Drug-Procurement Guidelines
  • FDA Issues Guidance for Manufacturing Cell-Based Viral Vaccines
  • PhRMA Seeks Policy Changes to Proposed Russian Pharmaceutical Law

• Blogroll

  • Applied Clinical Trials Blog
  • Beaker’s Blog
  • cafepharma
  • Carl's Blog on FDA Stuff
  • Compliance Zen
  • Eye on FDA
  • FDA Matters
  • FDA Transparency Blog
  • In the Pipeline
  • InternetDrugNews
  • Pharmalot
  • PharmExecBlog
  • SOCMA’s President Joe Acker’s Blog
  • WSJ’s Health Blog

• Archives

  • March 2010 (9)
  • February 2010 (11)
  • January 2010 (13)
  • December 2009 (12)
  • November 2009 (13)
  • October 2009 (16)
  • September 2009 (13)
  • August 2009 (18)
  • July 2009 (18)
  • June 2009 (19)
  • May 2009 (16)
  • April 2009 (19)
  • March 2009 (19)
  • February 2009 (17)
  • January 2009 (15)
  • December 2008 (14)
  • November 2008 (15)
  • October 2008 (21)
  • September 2008 (19)
  • August 2008 (14)
  • July 2008 (18)
  • June 2008 (18)
  • May 2008 (19)
  • April 2008 (16)
  • March 2008 (25)